Facing the evidence: antidepressant treatment in children and adolescents.
作者信息
Garland E Jane
机构信息
Mood and Anxiety Disorders Clinic, British Columbia's Children's Hospital, University of British Columbia, Vancouver BC.
出版信息
CMAJ. 2004 Feb 17;170(4):489-91.
Abstract
摘要
相似文献
1
Facing the evidence: antidepressant treatment in children and adolescents.面对证据：儿童和青少年的抗抑郁治疗
CMAJ. 2004 Feb 17;170(4):489-91.
2
Antidepressants and adverse effects in young patients: uncovering the evidence.青少年患者使用抗抑郁药及其不良反应：探寻相关证据。
CMAJ. 2004 Feb 17;170(4):487-9.
3
UK psychiatrists question SSRI warnings for under-18s.英国精神病学家对给18岁以下青少年使用选择性5-羟色胺再摄取抑制剂（SSRI）的警示提出质疑。
CMAJ. 2004 Feb 17;170(4):455.
4
Potential effects of antidepressant agents on the growth and development of children and adolescents.
J Psychosoc Nurs Ment Health Serv. 2005 Jan;43(1):22-35. doi: 10.3928/02793695-20050101-06.
5
Questions about SSRI antidepressant drug regulation.关于选择性5-羟色胺再摄取抑制剂（SSRI）类抗抑郁药物监管的问题。
Lancet. 2004;364(9434):577. doi: 10.1016/S0140-6736(04)16838-4.
6
Do selective serotonin reuptake inhibitors cause suicide? Antidepressant prescribing to children and adolescents by GPs has fallen since CSM advice.
BMJ. 2005 May 14;330(7500):1151. doi: 10.1136/bmj.330.7500.1151.
7
Are selective serotonin reuptake inhibitors a risk factor for adolescent suicide?选择性5-羟色胺再摄取抑制剂是青少年自杀的一个风险因素吗？
Can J Psychiatry. 2009 Feb;54(2):69-71; discussion 76-7. doi: 10.1177/070674370905400201.
8
[Antidepressant agents in the therapy of severe depression in adolescents].[抗抑郁药在青少年重度抑郁症治疗中的应用]
Duodecim. 1999;115(1):36-44.
9
FDA questions antidepressant safety for children.美国食品药品监督管理局质疑儿童使用抗抑郁药的安全性。
Lancet. 2003 Nov 8;362(9395):1558. doi: 10.1016/S0140-6736(03)14787-3.
10
Antidepressants and suicide: rising prescription rate does not mean rising rate of new users.抗抑郁药与自杀：处方率上升并不意味着新使用者的比率上升。
BMJ. 2004 Aug 21;329(7463):461; author reply 461-2. doi: 10.1136/bmj.329.7463.461.
引用本文的文献
1
Antidepressant Use in Medicaid-Insured Youth: Trends, Covariates, and Future Research Needs.医疗补助保险覆盖的青少年使用抗抑郁药情况：趋势、协变量及未来研究需求
Front Psychiatry. 2020 Mar 13;11:113. doi: 10.3389/fpsyt.2020.00113. eCollection 2020.
2
Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists.探索肿瘤坏死因子α拮抗剂的潜在抗抑郁机制。
Front Neurosci. 2019 Feb 11;13:98. doi: 10.3389/fnins.2019.00098. eCollection 2019.
3
Defining publication bias: protocol for a systematic review of highly cited articles and proposal for a new framework.定义发表偏倚：对高引文章进行系统评价的方案及新框架的提出。
Syst Rev. 2013 May 21;2:34. doi: 10.1186/2046-4053-2-34.
4
Antidepressant use in children and adolescents: Practice touch points to guide paediatricians.儿童和青少年使用抗抑郁药：指导儿科医生的实践要点
Paediatr Child Health. 2011 Nov;16(9):549-53. doi: 10.1093/pch/16.9.549.
5
Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade.儿科人群中精神药物的药物不良反应：对向丹麦药品管理局报告的十年数据的分析
BMC Res Notes. 2010 Jun 23;3:176. doi: 10.1186/1756-0500-3-176.
6
Reporting bias in medical research - a narrative review.医学研究中的报告偏倚——叙述性综述。
Trials. 2010 Apr 13;11:37. doi: 10.1186/1745-6215-11-37.
7
Antidepressant use in adolescence: We're asking the wrong questions.青少年使用抗抑郁药：我们问错问题了。
Paediatr Child Health. 2004 Oct;9(8):539-540. doi: 10.1093/pch/9.8.539.
8
Treating depressed children with antidepressants: more harm than benefit?用抗抑郁药治疗抑郁儿童：弊大于利？
J Clin Psychol Med Settings. 2008 Jun;15(2):92-7. doi: 10.1007/s10880-008-9108-9.
9
Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.儿童非适应证精神药理学处方：历史支持密切临床监测。
Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):24. doi: 10.1186/1753-2000-2-24.
10
Manufacturing consensus.
Cult Med Psychiatry. 2006 Jun;30(2):135-56. doi: 10.1007/s11013-006-9013-3.
本文引用的文献
1
Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients.帕罗西汀（帕罗西汀片、赛乐特）：儿科患者自杀风险增加。
CMAJ. 2003 Sep 2;169(5):446.
2
Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.舍曲林治疗儿童和青少年重度抑郁症的疗效：两项随机对照试验。
JAMA. 2003 Aug 27;290(8):1033-41. doi: 10.1001/jama.290.8.1033.
3
A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors.
J Child Adolesc Psychopharmacol. 2003 Summer;13(2):143-52. doi: 10.1089/104454603322163862.
4
Scope and impact of financial conflicts of interest in biomedical research: a systematic review.生物医学研究中经济利益冲突的范围与影响：一项系统综述
JAMA. 2003;289(4):454-65. doi: 10.1001/jama.289.4.454.
5
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.一项关于医学院校与行业赞助商之间临床试验协议条款的全国性调查。
N Engl J Med. 2002 Oct 24;347(17):1335-41. doi: 10.1056/NEJMsa020349.
6
Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.氟西汀用于儿童和青少年抑郁症的急性治疗：一项安慰剂对照的随机临床试验。
J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1205-15. doi: 10.1097/00004583-200210000-00010.
7
Rising prevalence of antidepressants among US youths.美国青少年中抗抑郁药的使用日益普遍。
Pediatrics. 2002 May;109(5):721-7. doi: 10.1542/peds.109.5.721.
8
Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.帕罗西汀治疗青少年重度抑郁症的疗效：一项随机对照试验。
J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72. doi: 10.1097/00004583-200107000-00010.
9
Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. AACAP.儿童和青少年抑郁症评估与治疗的实践参数。美国儿童和青少年精神科医师学会
J Am Acad Child Adolesc Psychiatry. 1998 Oct;37(10 Suppl):63S-83S. doi: 10.1097/00004583-199810001-00005.
10
Childhood and adolescent depression: a review of the past 10 years. Part II.儿童及青少年抑郁症：过去十年回顾。第二部分。
J Am Acad Child Adolesc Psychiatry. 1996 Dec;35(12):1575-83. doi: 10.1097/00004583-199612000-00008.
Zotero 插件